Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children : Global Asthma Network Phase I
© 2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd..
BACKGROUND: The Global Asthma Network (GAN), by using the International Study of Asthma and Allergies in Childhood (ISAAC) methodology, has updated trends in prevalence of symptoms of childhood allergic diseases, including non-infective rhinitis and conjunctivitis ('rhinoconjunctivitis'), which is reported here.
METHODS: Prevalence and severity of rhinoconjunctivitis were assessed by questionnaire among schoolchildren in GAN Phase I and ISAAC Phase I and III surveys 15-23 years apart. Absolute rates of change in prevalence were estimated for each centre and modelled by multi-level linear regression to compare trends by age group, time period and per capita national income.
RESULTS: Twenty-seven GAN centres in 14 countries surveyed 74,361 13- to 14-year-olds ('adolescents') and 45,434 6- to 7-year-olds ('children'), with average response proportions of 90% and 79%, respectively. Many centres showed highly significant (p < .001) changes in prevalence of rhinoconjunctivitis in the past year ('current rhinoconjunctivitis') compared with ISAAC. The direction and magnitude of centre-level trends varied significantly (p < .001) both within and between countries. Overall, current rhinoconjunctivitis prevalence decreased slightly from ISAAC Phase III to GAN: -1.32% per 10 years, 95% CI [-2.93%, +0.30%] among adolescents; and -0.44% [-1.29%, +0.42%] among children. Together, these differed significantly (p < .001) from the upward trend within ISAAC. Among adolescents, centre-level trends in current rhinoconjunctivitis were highly correlated with those for eczema symptoms (rho = 0.72, p < .0001) but not with centre-level trends in asthma symptoms (rho = 0.15, p = .48). Among children, these correlations were positive but not significant.
CONCLUSION: Symptoms of non-infective rhinoconjunctivitis among schoolchildren may no longer be on the increase globally, although trends vary substantially within and between countries.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology - 33(2022), 1 vom: 28. Jan., Seite e13656 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Strachan, David P [VerfasserIn] |
---|
Links: |
---|
Themen: |
Allergic disease |
---|
Anmerkungen: |
Date Completed 17.03.2022 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/pai.13656 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329966790 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329966790 | ||
003 | DE-627 | ||
005 | 20231225210254.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/pai.13656 |2 doi | |
028 | 5 | 2 | |a pubmed24n1099.xml |
035 | |a (DE-627)NLM329966790 | ||
035 | |a (NLM)34453861 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Strachan, David P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children |b Global Asthma Network Phase I |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.03.2022 | ||
500 | |a Date Revised 05.10.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. | ||
520 | |a BACKGROUND: The Global Asthma Network (GAN), by using the International Study of Asthma and Allergies in Childhood (ISAAC) methodology, has updated trends in prevalence of symptoms of childhood allergic diseases, including non-infective rhinitis and conjunctivitis ('rhinoconjunctivitis'), which is reported here | ||
520 | |a METHODS: Prevalence and severity of rhinoconjunctivitis were assessed by questionnaire among schoolchildren in GAN Phase I and ISAAC Phase I and III surveys 15-23 years apart. Absolute rates of change in prevalence were estimated for each centre and modelled by multi-level linear regression to compare trends by age group, time period and per capita national income | ||
520 | |a RESULTS: Twenty-seven GAN centres in 14 countries surveyed 74,361 13- to 14-year-olds ('adolescents') and 45,434 6- to 7-year-olds ('children'), with average response proportions of 90% and 79%, respectively. Many centres showed highly significant (p < .001) changes in prevalence of rhinoconjunctivitis in the past year ('current rhinoconjunctivitis') compared with ISAAC. The direction and magnitude of centre-level trends varied significantly (p < .001) both within and between countries. Overall, current rhinoconjunctivitis prevalence decreased slightly from ISAAC Phase III to GAN: -1.32% per 10 years, 95% CI [-2.93%, +0.30%] among adolescents; and -0.44% [-1.29%, +0.42%] among children. Together, these differed significantly (p < .001) from the upward trend within ISAAC. Among adolescents, centre-level trends in current rhinoconjunctivitis were highly correlated with those for eczema symptoms (rho = 0.72, p < .0001) but not with centre-level trends in asthma symptoms (rho = 0.15, p = .48). Among children, these correlations were positive but not significant | ||
520 | |a CONCLUSION: Symptoms of non-infective rhinoconjunctivitis among schoolchildren may no longer be on the increase globally, although trends vary substantially within and between countries | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a allergic disease | |
650 | 4 | |a conjunctivitis | |
650 | 4 | |a prevalence | |
650 | 4 | |a rhinitis | |
650 | 4 | |a time trend | |
700 | 1 | |a Rutter, Charlotte E |e verfasserin |4 aut | |
700 | 1 | |a Asher, Monica Innes |e verfasserin |4 aut | |
700 | 1 | |a Bissell, Karen |e verfasserin |4 aut | |
700 | 1 | |a Chiang, Chen-Yuan |e verfasserin |4 aut | |
700 | 1 | |a El Sony, Asma |e verfasserin |4 aut | |
700 | 1 | |a Ellwood, Eamon |e verfasserin |4 aut | |
700 | 1 | |a Ellwood, Philippa |e verfasserin |4 aut | |
700 | 1 | |a García-Marcos, Luis |e verfasserin |4 aut | |
700 | 1 | |a Marks, Guy B |e verfasserin |4 aut | |
700 | 1 | |a Morales, Eva |e verfasserin |4 aut | |
700 | 1 | |a Mortimer, Kevin |e verfasserin |4 aut | |
700 | 1 | |a Pearce, Neil |e verfasserin |4 aut | |
700 | 1 | |a Pérez-Fernández, Virginia |e verfasserin |4 aut | |
700 | 1 | |a Robertson, Steven |e verfasserin |4 aut | |
700 | 1 | |a Silverwood, Richard J |e verfasserin |4 aut | |
700 | 0 | |a Global Asthma Network Phase I Study Group |e verfasserin |4 aut | |
700 | 1 | |a Navarrete-Rodriguez, E M |e investigator |4 oth | |
700 | 1 | |a López-Silvarrey Varela, A |e investigator |4 oth | |
700 | 1 | |a Asher, M I |e investigator |4 oth | |
700 | 1 | |a Bissell, K |e investigator |4 oth | |
700 | 1 | |a Chiang, C-Y |e investigator |4 oth | |
700 | 1 | |a El Sony, A |e investigator |4 oth | |
700 | 1 | |a Ellwood, P |e investigator |4 oth | |
700 | 1 | |a García-Marcos, L |e investigator |4 oth | |
700 | 1 | |a Mortimer, K |e investigator |4 oth | |
700 | 1 | |a Pearce, N |e investigator |4 oth | |
700 | 1 | |a Strachan, D P |e investigator |4 oth | |
700 | 1 | |a Ellwood, P |e investigator |4 oth | |
700 | 1 | |a Ellwood, E |e investigator |4 oth | |
700 | 1 | |a Asher, M I |e investigator |4 oth | |
700 | 1 | |a García-Marcos, L |e investigator |4 oth | |
700 | 1 | |a Perez-Fernández, V |e investigator |4 oth | |
700 | 1 | |a Morales, E |e investigator |4 oth | |
700 | 1 | |a Martinez-Torres, A |e investigator |4 oth | |
700 | 1 | |a Strachan, D P |e investigator |4 oth | |
700 | 1 | |a Pearce, N |e investigator |4 oth | |
700 | 1 | |a Robertson, S |e investigator |4 oth | |
700 | 1 | |a Rutter, C E |e investigator |4 oth | |
700 | 1 | |a Silverwood, R J |e investigator |4 oth | |
700 | 1 | |a Mallol, J |e investigator |4 oth | |
700 | 1 | |a Soto-Martinez, M |e investigator |4 oth | |
700 | 1 | |a Singh, M |e investigator |4 oth | |
700 | 1 | |a Singh, V |e investigator |4 oth | |
700 | 1 | |a Awasthi, S |e investigator |4 oth | |
700 | 1 | |a Kabra, S K |e investigator |4 oth | |
700 | 1 | |a Salvi, S |e investigator |4 oth | |
700 | 1 | |a Mérida-Palacio, J V |e investigator |4 oth | |
700 | 1 | |a González-Díaz, S N |e investigator |4 oth | |
700 | 1 | |a Eleuterio González, José |e investigator |4 oth | |
700 | 1 | |a Sánchez, J F |e investigator |4 oth | |
700 | 1 | |a Falade, A |e investigator |4 oth | |
700 | 1 | |a Zar, H J |e investigator |4 oth | |
700 | 1 | |a López-Silvarrey Varela, A |e investigator |4 oth | |
700 | 1 | |a González Díaz, C |e investigator |4 oth | |
700 | 1 | |a García-Marcos, L |e investigator |4 oth | |
700 | 1 | |a Nour, M |e investigator |4 oth | |
700 | 1 | |a Dib, G |e investigator |4 oth | |
700 | 1 | |a Huang, J-L |e investigator |4 oth | |
700 | 1 | |a Chinratanapisit, S |e investigator |4 oth | |
700 | 1 | |a Soto-Quirós, M E |e investigator |4 oth | |
700 | 1 | |a El Sony, A |e investigator |4 oth | |
700 | 1 | |a Vichyanond, P |e investigator |4 oth | |
700 | 1 | |a Aguilar, P |e investigator |4 oth | |
700 | 1 | |a Soto-Quirós, M E |e investigator |4 oth | |
700 | 1 | |a Barba, S |e investigator |4 oth | |
700 | 1 | |a Sabir, M |e investigator |4 oth | |
700 | 1 | |a Kumar, L |e investigator |4 oth | |
700 | 1 | |a Singh, V |e investigator |4 oth | |
700 | 1 | |a Sukumaran, T U |e investigator |4 oth | |
700 | 1 | |a Awasthi, S |e investigator |4 oth | |
700 | 1 | |a Sharma, S K |e investigator |4 oth | |
700 | 1 | |a Hanumante, N M |e investigator |4 oth | |
700 | 1 | |a García-Almaráz, R |e investigator |4 oth | |
700 | 1 | |a Merida-Palacio, J V |e investigator |4 oth | |
700 | 1 | |a Del-Río-Navarro, B E |e investigator |4 oth | |
700 | 1 | |a González-Díaz, S N |e investigator |4 oth | |
700 | 1 | |a Eleuterio González, José |e investigator |4 oth | |
700 | 1 | |a Linares-Zapién, F J |e investigator |4 oth | |
700 | 1 | |a Asher, M I |e investigator |4 oth | |
700 | 1 | |a Sánchez, J F |e investigator |4 oth | |
700 | 1 | |a Zar, H J |e investigator |4 oth | |
700 | 1 | |a González Díaz, C |e investigator |4 oth | |
700 | 1 | |a García-Marcos, L |e investigator |4 oth | |
700 | 1 | |a Musa, Oaa |e investigator |4 oth | |
700 | 1 | |a Mohammad, Y |e investigator |4 oth | |
700 | 1 | |a Huang, J-L |e investigator |4 oth | |
700 | 1 | |a Vichyanond, P |e investigator |4 oth | |
700 | 1 | |a Aguirre, V |e investigator |4 oth | |
700 | 1 | |a Baeza-Bacab, M |e investigator |4 oth | |
700 | 1 | |a El Sony, A |e investigator |4 oth | |
700 | 1 | |a Mohammad, S |e investigator |4 oth | |
700 | 1 | |a Cortéz, E |e investigator |4 oth | |
700 | 1 | |a Soto-Quirós, M E |e investigator |4 oth | |
700 | 1 | |a Gratziou, C H |e investigator |4 oth | |
700 | 1 | |a Kumar, L |e investigator |4 oth | |
700 | 1 | |a Sukumaran, T U |e investigator |4 oth | |
700 | 1 | |a Chopra, K |e investigator |4 oth | |
700 | 1 | |a Hanumante, N M |e investigator |4 oth | |
700 | 1 | |a Asher, M I |e investigator |4 oth | |
700 | 1 | |a Onadeko, B O |e investigator |4 oth | |
700 | 1 | |a Rubio, A D |e investigator |4 oth | |
700 | 1 | |a García-Marcos, L |e investigator |4 oth | |
700 | 1 | |a Hsieh, K-H |e investigator |4 oth | |
700 | 1 | |a Mallol, J |e investigator |4 oth | |
700 | 1 | |a Shah, J |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology |d 1994 |g 33(2022), 1 vom: 28. Jan., Seite e13656 |w (DE-627)NLM075107252 |x 1399-3038 |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2022 |g number:1 |g day:28 |g month:01 |g pages:e13656 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/pai.13656 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 33 |j 2022 |e 1 |b 28 |c 01 |h e13656 |